Autosomal dominant osteosclerosis

Autosomal dominant osteosclerosis, most commonly encountered as autosomal dominant osteopetrosis type II (ADO II, Albers-Schönberg disease), is a heritable sclerosing bone disorder caused by impaired osteoclast-mediated bone resorption.[1][2] The condition results in generalized, abnormally increased bone density throughout the skeleton, including the jaws and skull base.[1][3] Despite historically being termed "benign osteopetrosis," up to 60–80% of individuals with radiographic signs develop clinically significant complications.[4][5] The pathogenesis centers on heterozygous missense variants in the CLCN7 gene (encoding a chloride/proton antiporter critical for osteoclast acidification of the resorption lacuna), which account for approximately 75% of ADO cases.[2][6] The resulting dominant-negative effect impairs osteoclast function while preserving osteoclast formation, leading to accumulation of unresorbed, structurally abnormal bone.[7][8] On dental radiographs, the hallmark is diffuse, generalized osteosclerosis of the jaws with thickened lamina dura and obliteration of medullary spaces.[9] Management is primarily supportive and directed at skeletal and dental complications.

The 2023 Nosology of Genetic Skeletal Disorders classifies this entity as "Osteopetrosis, late-onset, dominant form, CLCN7-related" (NOS 24-0100; OMIM 166600) within Group 24: Osteopetrosis and related osteoclast disorders.[10] The most widely used clinical name is autosomal dominant osteopetrosis type II (ADO II), also known as Albers-Schönberg disease after the radiologist who first described the condition in 1904.[1][3]

• The former designation "benign osteopetrosis" is now considered a misnomer given the frequency of significant complications and should be avoided.[3][5]
• ADO type I (OPTA1), previously grouped with osteopetrosis, has been reclassified as a high bone mass disease caused by LRP5 variants and is a distinct entity.[10][11]
• The umbrella term "marble bone disease" applies broadly to all forms of osteopetrosis and is not specific to ADO II.[1]

• Prevalence: Estimated at approximately 5 per 100,000, making ADO II the most common form of osteopetrosis.[12]
• Age of onset: Radiologic and clinical manifestations typically appear in late childhood or adolescence, though earlier presentation has been reported. Radiologic penetrance increases after age 20 and reaches approximately 60–90%.[3][4][12]
• Sex distribution: No consistent sex predilection.[3][13]
• Skeletal distribution: Osteosclerosis predominates in the spine and pelvis; the skull base, long bones, and jaws are also commonly involved. In the jaws, the maxilla may be more frequently or more severely affected than the mandible, though both are commonly involved.[1][3][9]

Presentation and symptoms

ADO II has a highly variable clinical course, ranging from asymptomatic (discovered incidentally on radiographs) to severely debilitating.[2][5] In the largest genetically confirmed series (94 subjects with CLCN7 variants), 92% had at least one disease sequela.[5]

• Fractures are the most common complication, occurring in 78–84% of affected individuals, with a mean of three fractures per patient. Fractures heal slowly and may occur after minimal trauma.[3][5]
• Scoliosis is present in approximately 24%.[3]
• Hip osteoarthritis develops in up to 27–50% and frequently requires arthroplasty.[3][12]

Oral and maxillofacial findings

• Osteomyelitis of the jaws is a well-documented and clinically important complication, reported in approximately 11–16% of ADO II patients. It is typically triggered by odontogenic infection (dental abscess or caries) and most commonly affects the mandible. The mandible's relatively limited blood supply, compounded by the dense, poorly vascularized osteopetrotic bone, predisposes to chronic, refractory infection.[3][4][5][14][15][16]
• Dental abnormalities include delayed or failed eruption of teeth, impacted teeth, and missing teeth. Enamel hypoplasia and increased susceptibility to caries have been described, particularly in more severe forms.[9][17][18][19]
• Cranial nerve compression from skull base osteosclerosis is rare in ADO II but can cause visual loss (up to 19%), hearing loss, or facial palsy.[4][5]

Red flags

Bone marrow failure (anemia, pancytopenia) occurs in approximately 3% of ADO subjects and, when present in childhood, should prompt consideration of more severe recessive forms.[4][5]

Location and distribution

Generalized, bilateral, symmetric osteosclerosis involves both jaws, often with the maxilla more prominently affected.[9] The skull base shows increased density, while the cranial vault may be thickened.[4][13] In ADO II specifically, skull base sclerosis predominates over vault sclerosis, distinguishing it from ADO type I where vault thickening is the more striking finding.[13]

Internal architecture

• Diffuse medullary sclerosis: The hallmark is a generalized increase in bone density with progressive obliteration of the normal medullary trabecular pattern and narrowing or complete loss of the medullary cavity. On panoramic radiographs, this produces a uniformly dense, "marble-like" appearance of the jaws.[9][20]
• Bone-within-bone (endobone) pattern: Concentric arcs of sclerotic bone within the medullary space are characteristic of ADO II and are most frequently observed in the iliac wings but may also be seen in other flat bones and occasionally in the jaws.[1][3]
• Alternating dense and lucent bands: Transverse bands of sclerosis perpendicular to the long axis are commonly seen in long bones and may be observed at the extremities of the mandibular rami.[4][12]

Periphery and shape

The overall jaw morphology is typically preserved without significant expansion, distinguishing osteopetrosis from conditions such as fibrous dysplasia or Paget disease. Cortical surfaces are thickened but maintain their normal contour.[9][21] No discrete mass or focal lesion is present; the process is diffuse and symmetric.

Effects on teeth and adjacent structures

• Lamina dura thickening: One of the earliest and most recognizable dental radiographic findings is progressive thickening of the lamina dura surrounding the teeth, which may eventually become so dense as to obscure the periodontal ligament space and root outlines.[9]
• Tooth eruption abnormalities: Delayed eruption, impaction, and congenital absence of teeth are common, reflecting impaired osteoclast-mediated resorption of alveolar bone necessary for tooth eruption.[9][17][22]
• Root morphology: Roots may appear shortened or malformed in severe cases; molar root formation defects have been documented in animal models of osteopetrosis.[19]
• Inferior alveolar canal: The canal may become difficult to identify due to surrounding medullary sclerosis and loss of the normal corticated canal walls.

Extent and cortical involvement

The process is polyostotic and symmetric, involving the entire skeleton. In the craniofacial region, the skull base is characteristically dense with narrowing of cranial nerve foramina, including the optic canals and internal auditory canals.[4][23] Paranasal sinuses may be poorly pneumatized or opacified due to surrounding sclerotic bone.[18]

Recognized variants and severity spectrum

Radiographic severity in ADO II varies considerably, even within the same family.[4][5] Quantitative CT of the lumbar spine shows the most extreme divergence from normal (Z-scores ranging from +3.6 to +38.7) and correlates with other markers of disease severity including fracture burden and bone marrow failure.[24] Individuals with the mildest radiographic features may have near-normal jaw appearances, while severely affected individuals show complete medullary obliteration.

MRI of the craniofacial skeleton

Cranial MRI demonstrates thickening and sclerosis of the calvarium with low signal intensity on both T1- and T2-weighted sequences in areas of dense bone.[18][23] In ADO II, optic nerve atrophy and optic canal stenosis are observed in a majority of patients undergoing cranial MRI, providing critical information for evaluating visual loss.[23] Dural venous sinus stenosis may also be identified.[23] MRI is the modality of choice for assessing cranial nerve compromise and intracranial complications such as hydrocephalus or tonsillar herniation, which are more common in severe forms.[23]

Bone scintigraphy

Radionuclide bone scans can demonstrate increased uptake throughout the skeleton, reflecting active but ineffective bone remodeling. In the craniofacial region, scintigraphy may identify areas of extramedullary hematopoiesis within the calvarium in severe cases.[18]

Diffuse, bilateral osteosclerosis of the jaws on dental radiographs narrows the differential to systemic conditions that produce generalized increased bone density. The key diagnostic step is recognizing the polyostotic, symmetric distribution and correlating with skeletal survey findings and family history.

The highest-risk diagnostic pitfall is misidentifying jaw osteomyelitis complicating osteopetrosis as primary chronic osteomyelitis, which may delay recognition of the underlying systemic bone disorder. When diffuse jaw sclerosis is encountered, a skeletal survey and family history should be obtained; genetic testing via a multigene osteopetrosis panel or exome sequencing confirms the diagnosis.[4]

Bone tissue findings

Iliac crest biopsy in ADO II demonstrates increased cortical width and increased eroded surfaces with significantly elevated numbers of large, multinucleated osteoclasts.[7][21] Despite their abundance, these osteoclasts are functionally impaired: they form a normal clear zone but are deficient in ruffled border formation, the specialized membrane domain required for bone resorption.[7][32] In vitro studies confirm that ADO II osteoclasts resorb bone at only 10–20% of normal levels due to impaired chloride transport and insufficient acidification of the resorption lacuna.[7]

Mandibular cortical bone

Undecalcified histology of mandibular cortical bone in ADO II reveals highly mineralized, thickened cement lines with osteocalcin deposition, reflecting cycles of defective resorption followed by compensatory formation.[32] Contact microradiography confirms markedly increased mineral content (CaMean T-score +10.1) and elevated frequency of maximally mineralized bone, consistent with continued mineral accumulation and absent remodeling.[33] Woven bone and retained mineralized cartilage may be interspersed with lamellar bone.[33]

Radiologic-pathologic correlation

The diffuse radiographic sclerosis directly reflects the accumulation of unresorbed, hypermineralized bone with obliterated marrow spaces. The thickened lamina dura corresponds histologically to dense, poorly remodeled alveolar bone surrounding the teeth. The propensity for osteomyelitis is explained by the diminished vascularity of the dense bone and compromised marrow-based immune response.[14]

Molecular correlation

The dominant-negative mechanism of heterozygous CLCN7 missense variants explains the incomplete penetrance (60–90%) and variable expressivity observed clinically.[6][8] The most common pathogenic variant is p.G215R (also reported as p.G213R), though numerous other missense variants have been identified without a definitive genotype-phenotype correlation.[5][8][34]

Diagnosis and workup

• Diagnosis is primarily radiologic, based on characteristic skeletal survey findings (sandwich vertebrae, endobone pattern, skull base sclerosis).[3][4]
• Confirmation requires molecular genetic testing, ideally via a multigene osteopetrosis panel or whole-exome sequencing rather than single-gene analysis.[4]
• Baseline evaluation should include complete blood count (to assess for bone marrow failure), serum alkaline phosphatase, calcium, ophthalmologic examination, and audiometry.[4][5]
• Bone biopsy is generally not recommended due to the risk of precipitating osteomyelitis in the dense, poorly vascularized bone.[9]

Dental management

Prevention of osteomyelitis is a central concern. Aggressive preventive dental care—including caries prevention, periodontal maintenance, and avoidance of elective extractions when possible—is essential.[4][14] When dental extraction is unavoidable, prolonged antibiotic prophylaxis and close postoperative monitoring are recommended.[16] Jaw osteomyelitis, when it occurs, is notoriously difficult to treat; management may require prolonged antibiotic therapy, hyperbaric oxygen, sequestrectomy, and in refractory cases partial jaw resection.[15][16] Complete healing is achieved in fewer than half of reported cases of maxillary osteomyelitis.[16]

Orthopedic and systemic management

Fracture management is complicated by delayed healing, high rates of nonunion, and surgical complications (infection, prosthesis loosening, intraoperative fracture) occurring in approximately 50% of operated patients.[3][12] No curative pharmacologic therapy exists for ADO II. Hematopoietic stem cell transplantation, the treatment of choice for severe autosomal recessive forms, is not established for ADO II and carries uncertain benefit relative to its risks.[35][36] Interferon gamma-1b has been used in severe recessive forms but is not standard for ADO II.[36]

Prognosis

ADO II is a lifelong condition with a clinical phenotype that worsens over time.[5] Life expectancy is generally normal, though rarely the condition can be fatal.[12] Fracture burden correlates with bone mineral density and inversely with bone resorption markers, providing potential biomarkers for disease severity monitoring.[37] Genetic counseling should be offered given the 50% transmission risk to offspring and the variable expressivity, including the possibility of asymptomatic gene carriers.[4][5]

Incomplete penetrance and variable expressivity

A distinctive feature of ADO II is its incomplete penetrance (60–90%), meaning that a substantial proportion of individuals carrying a pathogenic CLCN7 variant have no radiographic or clinical manifestations.[3][5][12] Unaffected gene carriers show significantly increased bone mineral density compared with controls but do not have increased fracture risk.[5] This variability, which occurs even within the same family, complicates genetic counseling and may be influenced by modifier genes.[6][8]

Overlap with recessive forms

Heterozygous CLCN7 variants can occasionally produce a phenotype severe enough to overlap with intermediate autosomal recessive osteopetrosis, including early-onset anemia and optic nerve compression.[4][8] When osteopetrosis presents in early childhood with severe manifestations, recessive inheritance should be considered even if only a heterozygous CLCN7 variant is initially identified, as deep intronic or regulatory variants may be missed by standard sequencing.[4][33]